Analysis of residual disease in periocular basal cell carcinoma following hedgehog pathway inhibition: Follow up to the VISORB trial

Analysis of residual disease in periocular basal cell carcinoma following hedgehog pathway inhibition: Follow up to the VISORB trial

Show other versions (1)

Basal cell carcinoma (BCC) is a common skin cancer caused by deregulated hedgehog signaling. BCC is often curable surgically; however, for orbital and periocular BCCs (opBCC), surgical excision may put visual function at risk. Our recent clinical trial highlighted the utility of vismodegib for prese...

Full description

Bibliographic Details
Main Authors: Shelby P. Unsworth, Christina F. Tingle, Curtis J. Heisel, Emily A. Eton, Christopher A. Andrews, May P. Chan, Scott C. Bresler, Alon Kahana
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714843/?tool=EBI

Similar Items

Similar Items